(S)-4-((tert-Butoxycarbonyl)amino)-5-methoxy-5-oxopentanoic acid, 95.0%, 1g

(S)-5-tert-Butyl 1-methyl 2-aminopentanedioate, 95.0%, 1g

1-Heptanol, mínimo 99 %, para síntesis, 500 ml, envase de vidrio

4-(4-Bromo-phenyl)-butyric acid methyl ester, 95%, 500mg

4,4'-(2-(4-Bromophenyl)-2-phenylethene-1,1-diyl)bis(N,N-dimethylaniline), 97%, 100mg

trans-1,2-Bis(phenylsulfonyl)ethylene>98.0%(HPLC)1g

Espátulas dobles de acero inoxidable rígidas, 300 mm, 16 mm, 1 Pieza

(1R*,4R*)-N1-Benzylcyclohexane-1,4-diamine dihydrochloride, 1g

(Methylsulfonyl)acetic Acid>98.0%(T)1g

1-(6-CHLOROPYRIDIN-3-YL)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 100mg

Boc-Tyr-OH, 98%, 10g

(9H-Fluoren-9-yl)methyl (6-(bis(4-methoxyphenyl)(phenyl)methoxy)-5-(hydroxymethyl)hexyl)carbamate, 95+%, 100mg

2-(4-Methoxybenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 1g